Skip to Content

Sanford Consortium for Regenerative Medicine and Takeda Pharmaceutical Company Innovation Alliance

Overview

The Sanford Consortium for Regenerative Medicine and the Takeda Pharmaceutical Company have established a five-year, $10-million Innovation Alliance to foster scientific collaborations and advance each organization’s research missions. Through this partnership, basic and translational stem-cell research projects entailing novel and integrative concepts and methods will be identified and supported.

During the first application cycle (September 2015 – April 2016) Takeda and Consortium investigators completed a process for soliciting, prioritizingand co-developing research proposals resulting in the recent funding of multiple projects.